Compare Enveric Biosciences Inc (ENVB) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Nano Dimension Ltd - ADR — how do they compare? Enveric Biosciences Inc trades at $1.39 (market cap $5.32M), while Nano Dimension Ltd - ADR trades at $1.48 (market cap $312.60M). The key difference: Nano Dimension Ltd - ADR is far larger — about 58.8× Enveric Biosciences Inc's market cap, and Nano Dimension Ltd - ADR is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | NNDM | |
|---|---|---|
Market Cap | $5.32M | $312.60M |
Sector | Health | Technology |
52-Week High | $17.40 | $2.14 |
52-Week Low | $1.28 | $1.21 |
Enterprise Value | $408.82K | -$96.74M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
NNDM trades at $1.50, up 1.35% today, but remains in a bearish technical trend with RSI levels indicating overbought conditions. The company reported Q1 2026 revenue of $102.44M but a net loss of $293.30M, reflecting persistent unprofitability. Recent news highlights boardroom conflicts with shareholder Murchinson and a proposed business combination with Infinite Epigenetics, adding uncertainty to the strategic direction.
The outlook for NNDM is highly speculative due to deep losses, negative cash flow, and governance disputes. While the low P/B ratio of 0.64 suggests undervaluation relative to assets, investment appeal is limited by cash burn and lack of earnings. Key risks include execution missteps, dilution from financing, and competitive pressure in additive manufacturing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →
